GeneDx Holdings Corp.
WGS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 50.8% | -13.7% | 10.6% | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 63.6% | 44.4% | -11.4% | -7.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -0.4% | -67.4% | -169.7% | -104% |
| Net Income | -$0 | -$0 | -$1 | -$0 |
| % Margin | -17.1% | -86.8% | -233.9% | -115.6% |
| EPS Diluted | -1.94 | -7.23 | -53.63 | -74.93 |
| % Growth | 73.2% | 86.5% | 28.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |